Literature DB >> 21359619

Monitoring and managing viral infections in pediatric renal transplant recipients.

Patrizia Comoli1, Fabrizio Ginevri.   

Abstract

Viral infections remain a significant cause of morbidity and mortality following renal transplantation. The pediatric cohort is at high risk of developing virus-related complications due to immunological naiveté and the increased alloreactivity risk that requires maintaining a heavily immunosuppressive environment. Although cytomegalovirus is the most common opportunistic pathogen seen in transplant recipients, numerous other viruses may affect clinical outcome. Recent technological advances and novel antiviral therapy have allowed implementation of viral and immunological monitoring protocols and adoption of prophylactic or preemptive treatment approaches in high-risk groups. These strategies have led to improved viral infection management in the immunocompromised host, with significant impact on outcome. We review the major viral infections seen following kidney transplantation and discuss strategies for preventing and managing these pathogens.

Entities:  

Mesh:

Year:  2011        PMID: 21359619     DOI: 10.1007/s00467-011-1812-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  110 in total

1.  Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.

Authors:  D Kumar; S Chernenko; G Moussa; I Cobos; O Manuel; J Preiksaitis; S Venkataraman; A Humar
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

Review 2.  Management of pediatric postrenal transplantation infections.

Authors:  V R Dharnidharka; W E Harmon
Journal:  Semin Nephrol       Date:  2001-09       Impact factor: 5.299

3.  Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells.

Authors:  Patrizia Comoli; Rita Maccario; Franco Locatelli; Umberto Valente; Sabrina Basso; Alberto Garaventa; Paolo Tomà; Gerardo Botti; Giovanni Melioli; Fausto Baldanti; Arcangelo Nocera; Francesco Perfumo; Fabrizio Ginevri
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

4.  Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.

Authors:  J Yang; Q Tao; I W Flinn; P G Murray; L E Post; H Ma; S Piantadosi; M A Caligiuri; R F Ambinder
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

5.  Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease.

Authors:  Barbara Savoldo; Cliona M Rooney; Ruben E Quiros-Tejeira; Yvette Caldwell; Hans-Joachim Wagner; Timothy Lee; Milton J Finegold; Gianpietro Dotti; Helen E Heslop; John A Goss
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

6.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.

Authors:  A Savoie; C Perpête; L Carpentier; J Joncas; C Alfieri
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

7.  Influenza vaccination is efficacious and safe in renal transplant recipients.

Authors:  J Scharpé; P Evenepoel; B Maes; B Bammens; K Claes; A D Osterhaus; Y Vanrenterghem; W E Peetermans
Journal:  Am J Transplant       Date:  2007-12-19       Impact factor: 8.086

8.  Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation.

Authors:  Fausto Baldanti; Marta Gatti; Milena Furione; Stefania Paolucci; Carmine Tinelli; Patrizia Comoli; Pietro Merli; Franco Locatelli
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

9.  Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.

Authors:  R A McDonald; J M Smith; M Ho; R Lindblad; D Ikle; P Grimm; R Wyatt; M Arar; D Liereman; N Bridges; W Harmon
Journal:  Am J Transplant       Date:  2008-05       Impact factor: 8.086

10.  Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.

Authors:  Birgitta Kranz; Udo Vester; Anne-Margret Wingen; Silvio Nadalin; Andreas Paul; Christoph E Broelsch; Peter F Hoyer
Journal:  Pediatr Transplant       Date:  2008-06
View more
  8 in total

Review 1.  Renal transplantation in infants.

Authors:  Hannu Jalanko; Ilkka Mattila; Christer Holmberg
Journal:  Pediatr Nephrol       Date:  2015-06-27       Impact factor: 3.714

Review 2.  Viral-associated glomerulopathies in children.

Authors:  Scott E Wenderfer
Journal:  Pediatr Nephrol       Date:  2015-03-10       Impact factor: 3.714

Review 3.  Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.

Authors:  Patrizia Comoli; Michela Cioni; Sabrina Basso; Chiara Gagliardone; Leonardo Potenza; Enrico Verrina; Mario Luppi; Marco Zecca; Gian Marco Ghiggeri; Fabrizio Ginevri
Journal:  Clin Dev Immunol       Date:  2013-08-13

4.  Serological markers of viral, syphilitic and toxoplasmic infection in children and teenagers with nephrotic syndrome: case series from Mato Grosso State, Brazil.

Authors:  Silvania França da Silva Soares; Teresinha Lermen Donatti; Francisco José Dutra Souto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

5.  Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation.

Authors:  Faris Hashim; Jon A Gregg; Vikas R Dharnidharka
Journal:  Open Urol Nephrol J       Date:  2014-12-31

6.  Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age.

Authors:  Danilo Lofaro; Judith L Vogelzang; Karlijn J van Stralen; Kitty J Jager; Jaap W Groothoff
Journal:  Pediatr Nephrol       Date:  2016-02       Impact factor: 3.714

7.  Prospective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation.

Authors:  Vivian Kourí; Consuelo Correa; Pedro A Martínez; Lizet Sanchez; Alina Alvarez; Grehete González; César E Silverio; Norma Hondal; Jose Florin; Lourdes Pérez; Diana P Duran; Yardelis Perez; Nancy Cazorla; Dalmaris Gonzalez; Juan C Jaime; Alberto Arencibia; Sandra Sarduy; Lissette Pérez; Yudira Soto; Mabel González; Iliana Alvarez; Elvira Dorticós; Juan J Marchena; Luis Solar; Belsy Acosta; Clara Savón; Ulrich Hengge
Journal:  Springerplus       Date:  2014-05-16

8.  Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.

Authors:  David DeWolfe; Jinal Gandhi; Matthew R Mackenzie; Thomas A Broge; Evelyn Bord; Amaara Babwah; Didier A Mandelbrot; Martha Pavlakis; Francesca Cardarelli; Raphael Viscidi; Anil Chandraker; Chen S Tan
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.